| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |